Clinical Trials Directory

Trials / Completed

CompletedNCT06534086

Virtual Reality for Urological Procedures

Feasibility of a Virtual Reality Intervention for Patients Undergoing Urological Procedures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Manitoba · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

It is standard practice for most cystoscopies and vasectomies in an office or outpatient setting to be performed under local anesthesia while the patient is awake and conscious. However, given the conscious nature of these procedures, patients may experience anxiety-inducing stressors that they otherwise would not under general anesthesia. Stressors such as hearing surgical terminology, technical discussion, and injection of local anesthetic have been previously documented as sources of perioperative anxiety and pain in awake surgeries. The current study will examine the feasibility and pilot outcomes of Virtual Reality (VR) guided meditation therapy during cystoscopies and vasectomies. Feasibility will be examined through: (1) recruitment capability and resulting sample characteristics, (2) data collection procedures (including randomization) and outcome measures, and (3) participant acceptability and suitability of the VR intervention during the procedures. The investigators will also evaluate pilot outcomes of the VR intervention on pain, anxiety, and overall satisfaction with the procedure. Results of this study will inform the development of a large-scale randomized clinical trial (RCT) to evaluate the efficacy of this intervention. Participants will be asked to complete questionnaires before and after their procedure and will be asked for a verbal measure of their pain and anxiety during the procedure.

Conditions

Interventions

TypeNameDescription
DEVICEVirtual reality (VR) guided meditation therapyTripp application on Meta Quest 3 VR headset
OTHERTreatment as usualNo VR, local anesthetic only

Timeline

Start date
2024-06-06
Primary completion
2024-11-01
Completion
2024-11-01
First posted
2024-08-02
Last updated
2025-01-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06534086. Inclusion in this directory is not an endorsement.